Semaglutide is approved for chronic weight management in adults who meet specific BMI criteria, even without type 2 diabetes
Intestinal and brain cells contain prohormone convertase 1 (PC1), which is able to cleave proglucagon into Glicentin, Oxyntomodulin, GLP-1, GLP-2 and IP-2, while pancreatic islet cells contain prohormone convertase 2 (PC2), which capable of cleaving proglucagon into Glucagon and MPGF
Cardiovascular Benefits GLP-1 therapy contributes to heart health by improving key cardiovascular markers such as blood pressure and cholesterol levels, reducing long-term risk factors
Keeping a consistent schedule with Wegovy is essential for effective use of the medication
Genetic Factors and Individual Response Variability Emerging evidence suggests genetic variants in GLP-1 receptor, GIPR, FTO, and MC4R genes contribute to individual differences in weight loss response and appetite regulation
As we move forward, the collaboration between endocrinologists, primary care providers, and specialists in hormone therapy will be key to navigating the complexities of treating conditions that involve both metabolic and hormonal components